ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,623,000 | +214.5% | 12,930 | +220.4% | 0.07% | +62.8% |
| Q4 2020 | $516,000 | +108.9% | 4,036 | +55.6% | 0.04% | +4.9% |
| Q2 2020 | $247,000 | -44.7% | 2,594 | -47.8% | 0.04% | -24.1% |
| Q1 2020 | $447,000 | -27.9% | 4,973 | -57.5% | 0.05% | +5.9% |
| Q4 2019 | $620,000 | -16.6% | 11,700 | -37.8% | 0.05% | +13.3% |
| Q3 2019 | $743,000 | +23.0% | 18,800 | +27.9% | 0.04% | -13.5% |
| Q2 2019 | $604,000 | – | 14,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |